Koji Morimoto

Title: Koji Morimoto: Innovator in Exocrine Gland Research

Introduction

Koji Morimoto is a notable inventor based in Neyagawa, Japan. He has made significant contributions to the field of molecular biology, particularly in understanding the proteins that constitute tight junctions in exocrine glands. With a total of 2 patents, Morimoto's work has implications for various biological and medical applications.

Latest Patents

Morimoto's latest patents focus on the exocrine gland tight junction-constituting protein JEAP family. A mouse cDNA library was screened from gene fragments encoding proteins that localize at cell-cell junctions. This screening utilized a technique that visualizes the localization of proteins to identify a junction-enriched and -associated protein known as JEAP. A GenBank homology search was performed based on the obtained sequence, leading to the identification of JEAP-2. The use of prepared antibodies against these proteins revealed that they specifically express at tight junctions, particularly in exocrine glands.

Career Highlights

Throughout his career, Koji Morimoto has worked with prominent companies in the pharmaceutical and biotechnology sectors. He has been associated with Eisai R&D Management Co., Ltd. and Eisai Company, Limited. His work in these organizations has contributed to advancements in drug development and molecular research.

Collaborations

Morimoto has collaborated with several professionals in his field, including Miyuki Nishimura and Mayumi Asano. These collaborations have fostered a productive environment for research and innovation.

Conclusion

Koji Morimoto's contributions to the understanding of tight junction proteins in exocrine glands highlight his role as an important inventor in the field of molecular biology. His patents and collaborations reflect a commitment to advancing scientific knowledge and innovation.